US4242513A
(en)
|
1979-03-05 |
1980-12-30 |
Appleton Papers Inc. |
Lactone compounds containing a heterocyclic radical
|
WO1986007059A2
(en)
|
1985-05-25 |
1986-12-04 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Oxodiazine compounds
|
JPH05503919A
(ja)
|
1989-06-13 |
1993-06-24 |
スミスクライン・ビーチャム・コーポレイション |
単球および/またはマクロファージによるインターロイキン―1または腫瘍壊死因子生成の抑制
|
WO1990015534A1
(en)
|
1989-06-13 |
1990-12-27 |
Smithkline Beecham Corporation |
Monokine activity interference
|
AU622330B2
(en)
|
1989-06-23 |
1992-04-02 |
Takeda Chemical Industries Ltd. |
Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
|
KR910011852A
(ko)
|
1989-12-04 |
1991-08-07 |
폴 디. 매튜카이티스 |
신경독 장해 치료용 이미다조[1,2-a]피리디닐알킬 화합물
|
CA2084290A1
(en)
|
1990-06-12 |
1991-12-13 |
Jerry L. Adams |
Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases
|
US5137876A
(en)
|
1990-10-12 |
1992-08-11 |
Merck & Co., Inc. |
Nucleoside antiviral and anti-inflammatory compounds and compositions and methods for using same
|
EP0563286A4
(en)
|
1990-12-13 |
1995-01-11 |
Smithkline Beecham Corp |
Novel csaids
|
JPH06504779A
(ja)
|
1990-12-13 |
1994-06-02 |
スミスクライン・ビーチャム・コーポレイション |
新規csaids
|
US5486525A
(en)
|
1993-12-16 |
1996-01-23 |
Abbott Laboratories |
Platelet activating factor antagonists: imidazopyridine indoles
|
US5869486A
(en)
|
1995-02-24 |
1999-02-09 |
Ono Pharmaceutical Co., Ltd. |
Fused pyrimidines and pyriazines as pharmaceutical compounds
|
AU5348396A
(en)
|
1995-05-01 |
1996-11-21 |
Fujisawa Pharmaceutical Co., Ltd. |
Imidazo 1,2-a pyridine and imidazo 1,2-a pyridezine derivati ves and their use as bone resorption inhibitors
|
US6992188B1
(en)
|
1995-12-08 |
2006-01-31 |
Pfizer, Inc. |
Substituted heterocyclic derivatives
|
TR199802685T2
(xx)
*
|
1996-06-25 |
1999-03-22 |
Pfizer Inc |
�kameli/katk�l� indazol t�revleri
|
US20010007867A1
(en)
|
1999-12-13 |
2001-07-12 |
Yuhpyng L. Chen |
Substituted 6,5-hetero-bicyclic derivatives
|
WO1998035967A2
(en)
|
1997-02-18 |
1998-08-20 |
Neurocrine Biosciences, Inc. |
Biazacyclic crf antagonists
|
AU6691798A
(en)
|
1997-03-07 |
1998-09-22 |
Metabasis Therapeutics, Inc. |
Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase
|
US6245769B1
(en)
|
1997-09-02 |
2001-06-12 |
Dupont Pharmaceuticals Company |
Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone(CRH) antagonists, useful for treating CNS and stress-related disorders
|
US6248755B1
(en)
|
1999-04-06 |
2001-06-19 |
Merck & Co., Inc. |
Pyrrolidine modulators of chemokine receptor activity
|
JP4032566B2
(ja)
|
1999-06-21 |
2008-01-16 |
東レ株式会社 |
発光素子
|
JP2001057292A
(ja)
|
1999-08-20 |
2001-02-27 |
Toray Ind Inc |
発光素子
|
GB9919778D0
(en)
|
1999-08-21 |
1999-10-27 |
Zeneca Ltd |
Chemical compounds
|
IL139197A0
(en)
|
1999-10-29 |
2001-11-25 |
Pfizer Prod Inc |
Use of corticotropin releasing factor antagonists and related compositions
|
EP1293213A1
(en)
|
2000-02-14 |
2003-03-19 |
Japan Tobacco Inc. |
Preventives/remedies for postoperative stress
|
EP1149583A3
(en)
|
2000-04-13 |
2001-11-14 |
Pfizer Products Inc. |
Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
AU2001276903A1
(en)
|
2000-07-14 |
2002-01-30 |
Bristol-Myers Squibb Pharma Company |
Imidazo(1,2-a)pyrazines for the treatment of neurological disorders
|
WO2002034748A1
(en)
|
2000-10-24 |
2002-05-02 |
Sankyo Company, Limited |
Imidazopyridine derivatives
|
WO2002048146A2
(de)
|
2000-12-13 |
2002-06-20 |
Basf Aktiengesellschaft |
Verwendung von substituierten imidazoazinen, neue imidazoazine, verfahren zu deren herstellung, sowie sie enthaltende mittel
|
HUP0400726A3
(en)
|
2001-01-22 |
2007-05-29 |
Merck & Co Inc |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
TWI312347B
(en)
|
2001-02-08 |
2009-07-21 |
Eisai R&D Man Co Ltd |
Bicyclic nitrogen-containing condensed ring compounds
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
SE0100568D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
ES2316546T3
(es)
|
2001-02-20 |
2009-04-16 |
Astrazeneca Ab |
2-arilamino-pirimidinas para el tratamiento de trastornos asociados a gsk3.
|
CA2438586A1
(en)
|
2001-03-14 |
2002-09-19 |
Eli Lilly And Company |
Retinoid x receptor modulators
|
ES2310202T3
(es)
|
2001-04-26 |
2009-01-01 |
EISAI R&D MANAGEMENT CO., LTD. |
Compuesto ciclico condensado que contiene nitrogeno que tiene un grupo pirazolilo como grupo sustituyente y composicion farmaceutica del mismo.
|
EP1406611A2
(en)
|
2001-05-30 |
2004-04-14 |
Alteon, Inc. |
Method for treating fibrotic diseases or other indications
|
CA2448317A1
(en)
|
2001-05-30 |
2002-12-05 |
Alteon Inc. |
Method for treating glaucoma v
|
US7186714B2
(en)
|
2001-06-21 |
2007-03-06 |
Smithkline Beecham Corporation |
Imidazo[1,2-α]pyridine derivatives for the prophylaxis and treatment of herpes viral infections
|
US7196095B2
(en)
|
2001-06-25 |
2007-03-27 |
Merck & Co., Inc. |
(Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds
|
IL159811A0
(en)
|
2001-07-13 |
2004-06-20 |
Neurogen Corp |
Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands
|
ES2262893T3
(es)
|
2001-10-05 |
2006-12-01 |
Smithkline Beecham Corporation |
Derivados de imidazo-piridina para su uso en el tratamiento de infeccion virica por herpes.
|
CA2472682A1
(en)
|
2002-01-22 |
2003-07-31 |
Merck & Co., Inc. |
Treating stress response with chemokine receptor ccr5 modulators
|
AU2003215325B8
(en)
|
2002-03-05 |
2008-10-09 |
Eli Lilly And Company |
Purine derivatives as kinase inhibitors
|
JP2003313126A
(ja)
|
2002-04-23 |
2003-11-06 |
Sankyo Co Ltd |
イミダゾピリジン誘導体を有効成分とする医薬
|
JP2004002826A
(ja)
|
2002-04-24 |
2004-01-08 |
Sankyo Co Ltd |
高分子イミダゾピリジン誘導体
|
WO2003097062A1
(en)
|
2002-05-13 |
2003-11-27 |
Merck & Co., Inc. |
Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
|
AU2003237249A1
(en)
|
2002-05-24 |
2003-12-12 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having modified nucleoside units
|
GB0217783D0
(en)
|
2002-07-31 |
2002-09-11 |
Glaxo Group Ltd |
Compounds
|
AR040726A1
(es)
|
2002-07-31 |
2005-04-20 |
Smithkline Beecham Corp |
Compuesto de 2- fenilpiridin-4-il-heterociclico, composicion farmaceutica que lo comprende y su uso para la fabricacion de un medicamento
|
US7320995B2
(en)
|
2002-08-09 |
2008-01-22 |
Eli Lilly And Company |
Benzimidazoles and benzothiazoles as inhibitors of map kinase
|
AU2003255845A1
(en)
|
2002-08-22 |
2004-03-11 |
Piramed Limited |
Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
|
UA80296C2
(en)
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Imidazolopyridines and methods of making and using the same
|
US7312341B2
(en)
|
2002-09-09 |
2007-12-25 |
Cgi Pharmaceuticals, Inc. |
6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof
|
EP1539749A4
(en)
|
2002-09-13 |
2007-06-13 |
Merck & Co Inc |
BY CONDENSED HETEROBICYCLOGRUPPEN SUBSTITUTED PHENYL COMPOUNDS AS METOBOTROPE GLUTAMATE-5 MODULATORS
|
US6992080B2
(en)
|
2002-09-19 |
2006-01-31 |
Schering Corporation |
Imidazopyridines as cyclin dependent kinase inhibitors
|
PE20050081A1
(es)
|
2002-09-23 |
2005-03-01 |
Schering Corp |
Nuevas imidazopirazinas como inhibidores de cinasas dependientes de ciclinas
|
CA2499874A1
(en)
|
2002-09-23 |
2004-04-01 |
Schering Corporation |
Novel imidazopyrazines as cyclin dependent kinase inhibitors
|
US7576085B2
(en)
|
2002-09-23 |
2009-08-18 |
Schering Corporation |
Imidazopyrazines as cyclin dependent kinase inhibitors
|
AU2003271185A1
(en)
|
2002-10-15 |
2004-05-04 |
Takeda Pharmaceutical Company Limited |
Imidazopyridine derivative, process for producing the same, and use
|
CN1849142A
(zh)
|
2002-11-15 |
2006-10-18 |
埃迪尼克斯(开曼)有限公司 |
2′-支链核苷和黄病毒突变
|
AU2003284596A1
(en)
|
2002-11-22 |
2004-06-18 |
Takeda Pharmaceutical Company Limited |
Imidazole derivative, process for producing the same, and use
|
EP1582516B1
(en)
|
2003-01-10 |
2013-07-17 |
Idemitsu Kosan Co., Ltd. |
Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same
|
US7160885B2
(en)
|
2003-02-10 |
2007-01-09 |
Cgi Pharmaceuticals, Inc. |
Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity
|
US7186832B2
(en)
|
2003-02-20 |
2007-03-06 |
Sugen Inc. |
Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
|
US7329668B2
(en)
|
2003-02-25 |
2008-02-12 |
Bristol-Myers Squibb Company |
Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
|
PA8595001A1
(es)
|
2003-03-04 |
2004-09-28 |
Pfizer Prod Inc |
Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf)
|
US7041671B2
(en)
|
2003-04-02 |
2006-05-09 |
Pfizer Inc |
Pyrrolo[1,2-b]pyridazine compounds and their uses
|
US20060094699A1
(en)
|
2003-04-11 |
2006-05-04 |
Kampen Gita Camilla T |
Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist to minimize the side effects associated with glucocorticoid receptor agonist therapy
|
JP2006522750A
(ja)
|
2003-04-11 |
2006-10-05 |
ノボ ノルディスク アクティーゼルスカブ |
代謝性症候群ならびに関連の疾患および障害を治療するために、11β−ヒドロキシステロイドデヒドロゲナーゼ1型阻害剤および抗高血圧剤を使用する併用療法
|
US20060100235A1
(en)
|
2003-04-11 |
2006-05-11 |
Novo Nordisk A/S |
Pharmaceutical use of substituted 1,2,4-triazoles
|
WO2004103991A1
(fr)
|
2003-05-20 |
2004-12-02 |
'chemical Diversity Research Institute', Ltd. |
Piperidines 2-substituees, bibliotheque focalisee et composition pharmaceutique
|
WO2005020885A2
(en)
|
2003-05-21 |
2005-03-10 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
|
WO2004106276A1
(ja)
|
2003-05-30 |
2004-12-09 |
Takeda Pharmaceutical Company Limited |
縮合環化合物
|
US7405295B2
(en)
|
2003-06-04 |
2008-07-29 |
Cgi Pharmaceuticals, Inc. |
Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
|
WO2005005429A1
(en)
|
2003-06-30 |
2005-01-20 |
Cellular Genomics, Inc. |
Certain heterocyclic substituted imidazo[1,2-a]pyrazin-8-ylamines and methods of inhibition of bruton’s tyrosine kinase by such compounds
|
CA2532971A1
(en)
|
2003-07-14 |
2005-01-27 |
Arena Pharmaceuticals, Inc. |
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
|
US7259164B2
(en)
|
2003-08-11 |
2007-08-21 |
Cgi Pharmaceuticals, Inc. |
Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity
|
KR100553752B1
(ko)
|
2003-10-13 |
2006-02-20 |
삼성에스디아이 주식회사 |
이미다졸 고리 함유 화합물 및 이를 이용한 유기 전계발광 소자
|
AU2004287847A1
(en)
|
2003-10-28 |
2005-05-19 |
Sepracor Inc. |
Imidazo(1,2-a)pyridine anxiolytics
|
US20050288295A1
(en)
|
2003-11-11 |
2005-12-29 |
Currie Kevin S |
Certain imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
|
WO2005080355A1
(en)
|
2004-02-12 |
2005-09-01 |
Neurogen Corporation |
Imidazo-pyridazines, triazolo-pyridazines and related benzodiazepine receptor ligands
|
US7306631B2
(en)
|
2004-03-30 |
2007-12-11 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
JP2005343889A
(ja)
|
2004-05-06 |
2005-12-15 |
Taisho Pharmaceut Co Ltd |
イミダゾピリジン誘導体
|
ES2321315T3
(es)
|
2004-06-09 |
2009-06-04 |
Oncalis Ag |
Inhibidores de proteina kinasa.
|
GB0413605D0
(en)
|
2004-06-17 |
2004-07-21 |
Addex Pharmaceuticals Sa |
Novel compounds
|
ES2319797T3
(es)
*
|
2004-07-05 |
2009-05-12 |
Astellas Pharma Inc. |
Derivados de pirazolopiridina.
|
EP1790650B1
(en)
|
2004-08-31 |
2014-03-26 |
Msd Kk |
NEW SUBSTITUTED IMIDAZOLE DERIVATIVES
|
AU2005295734A1
(en)
|
2004-10-15 |
2006-04-27 |
Biogen Idec Ma Inc. |
Methods of treating vascular injuries
|
RU2007119637A
(ru)
|
2004-10-28 |
2008-12-10 |
Айрм Ллк (Bm) |
Соединения и композиции в качестве модуляторов hedgehog-пути
|
WO2006049339A1
(ja)
|
2004-11-08 |
2006-05-11 |
Banyu Pharmaceutical Co., Ltd. |
新規縮環イミダゾール誘導体
|
EP1812442A2
(en)
|
2004-11-10 |
2007-08-01 |
CGI Pharmaceuticals, Inc. |
Imidazo[1,2-a]pyrazin-8-ylamines useful as modulators of kinase activity
|
US20060128729A1
(en)
*
|
2004-11-23 |
2006-06-15 |
Manojit Pal |
Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them
|
US20080207634A1
(en)
|
2004-12-17 |
2008-08-28 |
Kristjan Gudmundsson |
Chemical Compounds
|
JPWO2006070943A1
(ja)
|
2004-12-28 |
2008-06-12 |
武田薬品工業株式会社 |
縮合イミダゾール化合物およびその用途
|
WO2006094235A1
(en)
|
2005-03-03 |
2006-09-08 |
Sirtris Pharmaceuticals, Inc. |
Fused heterocyclic compounds and their use as sirtuin modulators
|
MX2007011600A
(es)
*
|
2005-03-21 |
2007-12-07 |
Lilly Co Eli |
Compuestos de imidazopiridazina.
|
US7666880B2
(en)
|
2005-03-21 |
2010-02-23 |
S*Bio Pte Ltd. |
Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
|
TW200700064A
(en)
|
2005-03-24 |
2007-01-01 |
Glaxo Group Ltd |
Novel compounds
|
EP1879896A1
(en)
|
2005-04-05 |
2008-01-23 |
Eli Lilly And Company |
Imidazopyridazine compounds
|
US7572807B2
(en)
|
2005-06-09 |
2009-08-11 |
Bristol-Myers Squibb Company |
Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
|
GB0513423D0
(en)
|
2005-06-30 |
2005-08-03 |
Glaxo Group Ltd |
Novel compounds
|
AU2006268908A1
(en)
|
2005-07-11 |
2007-01-18 |
Novartis Ag |
Indolylmaleimide derivatives
|
US20100216798A1
(en)
|
2005-07-29 |
2010-08-26 |
Astellas Pharma Inc |
Fused heterocycles as lck inhibitors
|
WO2007025043A2
(en)
|
2005-08-23 |
2007-03-01 |
Idenix Pharmaceuticals, Inc. |
Seven-membered ring nucleosides
|
US20070049591A1
(en)
|
2005-08-25 |
2007-03-01 |
Kalypsys, Inc. |
Inhibitors of MAPK/Erk Kinase
|
TW200800213A
(en)
|
2005-09-02 |
2008-01-01 |
Abbott Lab |
Novel imidazo based heterocycles
|
US20070078136A1
(en)
*
|
2005-09-22 |
2007-04-05 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
US7723336B2
(en)
|
2005-09-22 |
2010-05-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
JP5048675B2
(ja)
|
2005-09-27 |
2012-10-17 |
エフ.ホフマン−ラ ロシュ アーゲー |
mGluR2アンタゴニストとしてのオキサジアゾリルピラゾロ−ピリミジン類
|
EP1934213A1
(en)
|
2005-09-30 |
2008-06-25 |
Astra Zeneca AB |
Imidazo [1,2-a] pyridine having anti-cell-proliferation activity
|
JO2769B1
(en)
|
2005-10-26 |
2014-03-15 |
جانسين فارماسوتيكا ان. في |
Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
|
EP1945216A1
(en)
|
2005-11-10 |
2008-07-23 |
Schering Corporation |
Methods for inhibiting protein kinases
|
KR20080074963A
(ko)
|
2005-11-10 |
2008-08-13 |
쉐링 코포레이션 |
단백질 키나제 억제제로서의 이미다조피라진
|
US7718657B2
(en)
|
2005-12-16 |
2010-05-18 |
Cytokinetics, Inc. |
Certain indanyl urea modulators of the cardiac sarcomere
|
EP2474546A1
(en)
|
2006-01-23 |
2012-07-11 |
Vertex Pharmaceuticals Inc. |
Thiophene-carboxamides useful as inhibitors of protein kinases
|
EP1984375A2
(en)
|
2006-01-25 |
2008-10-29 |
Smithkline Beecham Corporation |
Chemical compounds
|
JP2009528388A
(ja)
|
2006-03-02 |
2009-08-06 |
スミスクライン・ビーチャム・コーポレイション |
Pi3キナーゼ阻害物質として用いられるチアゾロン
|
US20090176829A1
(en)
*
|
2006-05-02 |
2009-07-09 |
Pfizer Inc |
Bicyclic heteroaryl compounds as pde10 inhibitors
|
US20090175852A1
(en)
|
2006-06-06 |
2009-07-09 |
Schering Corporation |
Imidazopyrazines as protein kinase inhibitors
|
CA2654202A1
(en)
|
2006-06-06 |
2007-12-21 |
Schering Corporation |
Imidazopyrazines as protein kinase inhibitors
|
ITVA20060041A1
(it)
|
2006-07-05 |
2008-01-06 |
Dialectica Srl |
Uso di composti derivati amminotiazolici, di loro composizioni farmaceutiche, nel trattamento di malattie caratterizzate dalla anormale repressione della trascrizione genica, particolarmente il morbo di huntington
|
CA2658764A1
(en)
|
2006-07-20 |
2008-01-24 |
Mehmet Kahraman |
Benzothiophene inhibitors of rho kinase
|
WO2008014219A2
(en)
|
2006-07-24 |
2008-01-31 |
Smithkline Beecham Corporation |
Thiozolidinedione derivatives as p13 kinase inhibitors
|
US7563797B2
(en)
|
2006-08-28 |
2009-07-21 |
Forest Laboratories Holding Limited |
Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligands
|
US20100144743A1
(en)
|
2006-09-05 |
2010-06-10 |
Board Of Regents, The University Of Texas System |
Compositions and methods for inhibition of tyrosine kinases
|
JP5600004B2
(ja)
|
2006-09-05 |
2014-10-01 |
エモリー ユニバーシティー |
感染の予防または治療のためのチロシンキナーゼ阻害剤
|
WO2008030579A2
(en)
|
2006-09-07 |
2008-03-13 |
Biogen Idec Ma Inc. |
Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder
|
US7790741B2
(en)
|
2006-10-06 |
2010-09-07 |
Abbott Laboratories |
Imidazothiazoles and imidazoxazoles
|
CA2612656A1
(en)
|
2006-10-30 |
2008-04-30 |
Draxis Specialty Pharmaceuticals Inc. |
Methods for preparing 2-methoxyisobutylisonitrile and tetrakis(2-methoxyisobutylisonitrile)copper(i) tetrafluoroborate
|
WO2008057402A2
(en)
|
2006-11-02 |
2008-05-15 |
Cytovia, Inc. |
N-aryl-isoxazolopyrimidin-4-amines and related compounds as activators of caspases and inducers of apoptosis and the use thereof
|
AR063581A1
(es)
|
2006-11-08 |
2009-02-04 |
Schering Corp |
Imidazopirazinas como inhibidores de proteina quinasa
|
US20080221092A1
(en)
|
2006-11-20 |
2008-09-11 |
Harald Bluhm |
Heterobicyclic metalloprotease inhibitors
|
US7622584B2
(en)
|
2006-11-24 |
2009-11-24 |
Samsung Mobile Display Co., Ltd. |
Imidazopyridine-based compound and organic light emitting diode including organic layer comprising the imidazopyridine-based compound
|
NZ578159A
(en)
|
2006-12-04 |
2012-01-12 |
Astrazeneca Ab |
Antibacterial polycyclic urea compounds
|
US7977336B2
(en)
|
2006-12-28 |
2011-07-12 |
Banyu Pharmaceutical Co. Ltd |
Aminopyrimidine derivatives as PLK1 inhibitors
|
US8138197B2
(en)
|
2007-01-12 |
2012-03-20 |
Msd K.K. |
Spirochromanon derivatives
|
US20080242862A1
(en)
|
2007-03-27 |
2008-10-02 |
Calderwood David J |
Novel imidazo based heterocycles
|
CN101679422A
(zh)
|
2007-03-28 |
2010-03-24 |
阵列生物制药公司 |
作为受体酪氨酸激酶抑制剂的咪唑并[1,2-a]吡啶化合物
|
EP2137184B1
(en)
|
2007-04-03 |
2013-05-08 |
Array Biopharma, Inc. |
Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
|
EA200970931A1
(ru)
|
2007-04-10 |
2010-04-30 |
Х. Лундбекк А/С |
Аналоги гетероариламидов
|
WO2008133192A1
(ja)
|
2007-04-19 |
2008-11-06 |
Takeda Pharmaceutical Company Limited |
縮合イミダゾール化合物およびその用途
|
WO2008134553A1
(en)
|
2007-04-26 |
2008-11-06 |
Xenon Pharmaceuticals Inc. |
Methods of using bicyclic compounds in treating sodium channel-mediated diseases
|
MX2009012066A
(es)
|
2007-05-09 |
2009-11-19 |
Novartis Ag |
Imidazopirinas sustituidas como inhibidoras de cinasa de lipido p13k.
|
JP2011513195A
(ja)
|
2007-05-10 |
2011-04-28 |
バイオクライスト ファーマシューティカルズ, インコーポレイテッド |
ウイルス感染およびがんの処置に使用するためのテトラヒドロフロ[3,4−d]ジオキソラン化合物
|
CN101932580B
(zh)
|
2007-06-01 |
2013-05-22 |
葛兰素史密丝克莱恩有限责任公司 |
咪唑并吡啶激酶抑制剂
|
WO2008156614A2
(en)
|
2007-06-14 |
2008-12-24 |
Schering Corporation |
Imidazopyrazines as protein kinase inhibitors
|
KR101030007B1
(ko)
|
2007-06-15 |
2011-04-20 |
삼성모바일디스플레이주식회사 |
헤테로방향환 함유 화합물, 이의 제조 방법 및 이를 이용한유기 발광 소자
|
JP2010531875A
(ja)
|
2007-06-26 |
2010-09-30 |
ギリード・サイエンシズ・インコーポレーテッド |
イミダゾピリジニルチアゾリルヒストンデアセチラーゼ阻害剤
|
WO2009005675A1
(en)
|
2007-06-28 |
2009-01-08 |
Abbott Laboratories |
Novel triazolopyridazines
|
FR2918061B1
(fr)
|
2007-06-28 |
2010-10-22 |
Sanofi Aventis |
Derives de 6-cycloamino-3-(pyridin-4-yl)imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique.
|
FR2918986B1
(fr)
|
2007-07-19 |
2009-09-04 |
Sanofi Aventis Sa |
Derives de 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]- pyridazine, leur preparation et leur application en therapeutique
|
JP2010534646A
(ja)
|
2007-07-27 |
2010-11-11 |
アクテリオン ファーマシューティカルズ リミテッド |
トランス−3−アザ−ビシクロ[3.1.0]ヘキサン誘導体
|
RU2010106878A
(ru)
|
2007-07-31 |
2011-09-10 |
Шеринг Корпорейшн (US) |
Комбинация антимитотического агента и ингибитора аврора киназы как средство для лечения рака
|
US20120121540A1
(en)
|
2007-08-10 |
2012-05-17 |
Franz Ulrich Schmitz |
Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections
|
JP5327652B2
(ja)
|
2007-08-14 |
2013-10-30 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
癌処理のための融合されたイミダゾール
|
EP2190844B3
(en)
|
2007-08-15 |
2013-07-17 |
Arena Pharmaceuticals, Inc. |
Imidazo[1,2-a]pyridine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
GB0716292D0
(en)
|
2007-08-21 |
2007-09-26 |
Biofocus Dpi Ltd |
Imidazopyrazine compounds
|
EP2217601A1
(en)
|
2007-11-08 |
2010-08-18 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyridazines for use as protein kinase inhibitors
|
EP2217069A4
(en)
|
2007-11-09 |
2012-03-14 |
Salk Inst For Biological Studi |
INHIBITORS OF NON-NUCLEOSIDE INHIBITORS OF THE REVERSE TRANSCRIPTASE
|
ES2462642T3
(es)
|
2007-12-14 |
2014-05-26 |
F. Hoffmann-La Roche Ag |
Nuevos derivados de imidazo[1,2-a]piridina e imidazo[1,2-b]piridazina
|
CN101945871A
(zh)
|
2007-12-21 |
2011-01-12 |
惠氏有限责任公司 |
咪唑并[1,2-a]吡啶化合物
|
WO2009086130A1
(en)
|
2007-12-21 |
2009-07-09 |
Wyeth |
Imidazo [1,2-b] pyridazine compounds as modulators of liver x receptors
|
JP5355421B2
(ja)
|
2007-12-21 |
2013-11-27 |
出光興産株式会社 |
有機エレクトロルミネッセンス素子
|
FR2926556B1
(fr)
|
2008-01-22 |
2010-02-19 |
Sanofi Aventis |
Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique
|
CA2710929A1
(en)
|
2008-01-28 |
2009-08-06 |
Schering Corporation |
Imidazopyrazines as protein kinase inhibitors
|
ATE555116T1
(de)
|
2008-02-26 |
2012-05-15 |
Merck Sharp & Dohme |
Ahcy-hydrolasehemmer zur behandlung von hyperhomocysteinämie
|
ES2413806T3
(es)
|
2008-03-20 |
2013-07-17 |
Amgen Inc. |
Moduladores de la aurora cinasa y método de uso
|
DE102008017853A1
(de)
|
2008-04-09 |
2009-10-15 |
Merck Patent Gmbh |
Thienopyrimidine
|
CA2721060A1
(en)
|
2008-04-09 |
2009-10-15 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
EA020659B1
(ru)
|
2008-04-23 |
2014-12-30 |
Джилид Сайэнс, Инк. |
1'-замещённые карбануклеозидные аналоги для противовирусной терапии
|
WO2010036407A2
(en)
|
2008-05-15 |
2010-04-01 |
Biocryst Pharmaceuticals, Inc. |
Antiviral nucleoside analogs
|
CA2724842A1
(en)
|
2008-05-19 |
2009-11-26 |
Sunovion Pharmaceuticals Inc. |
Imidazo[1,2-a]pyridine compounds
|
AR072008A1
(es)
|
2008-06-13 |
2010-07-28 |
Merck & Co Inc |
Compuestos heterobiciclicos como agentes de inhibicion de quinasa p38
|
EP2306836B1
(en)
|
2008-07-01 |
2016-09-07 |
PTC Therapeutics, Inc. |
Bmi-1 protein expression modulators
|
NZ602832A
(en)
|
2008-07-14 |
2014-04-30 |
Gilead Sciences Inc |
Fused heterocyclic hdac inhibitor compounds
|
WO2010011837A1
(en)
|
2008-07-24 |
2010-01-28 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
WO2010016005A1
(en)
|
2008-08-06 |
2010-02-11 |
Pfizer Inc. |
6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors
|
FR2934994B1
(fr)
|
2008-08-12 |
2010-09-17 |
Sanofi Aventis |
Derives de 2-alkyl-6cycloamino-3-(pyridin-4-yl)imidaz°1,2-b! pyridazine, leur preparation et leur application en therapeutique
|
US8198449B2
(en)
|
2008-09-11 |
2012-06-12 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
US20120021519A1
(en)
|
2008-09-19 |
2012-01-26 |
Presidents And Fellows Of Harvard College |
Efficient induction of pluripotent stem cells using small molecule compounds
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
JP5416944B2
(ja)
|
2008-10-23 |
2014-02-12 |
ユー・ディー・シー アイルランド リミテッド |
有機電界発光素子
|
WO2010059838A2
(en)
|
2008-11-20 |
2010-05-27 |
Decode Genetics Ehf |
Pde4 inhibitors selective for the long form of pde4 for treating inflammation and avoiding side effects
|
WO2010059836A1
(en)
|
2008-11-20 |
2010-05-27 |
Decode Genetics Ehf |
Substituted aza-bridged bicyclics for cardiovascular and cns disease
|
GB0822981D0
(en)
|
2008-12-17 |
2009-01-21 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
JP5210187B2
(ja)
|
2009-01-22 |
2013-06-12 |
ユー・ディー・シー アイルランド リミテッド |
有機電界発光素子
|
EP2210891A1
(en)
|
2009-01-26 |
2010-07-28 |
Domain Therapeutics |
New adenosine receptor ligands and uses thereof
|
WO2010088518A2
(en)
|
2009-01-31 |
2010-08-05 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
US8367222B2
(en)
|
2009-02-27 |
2013-02-05 |
Idemitsu Kosan Co., Ltd. |
Organic electroluminescent device
|
MX2011009796A
(es)
|
2009-03-20 |
2011-12-14 |
Amgen Inc |
Inhibidores de la cinasa pi3.
|
WO2010110277A1
(ja)
|
2009-03-24 |
2010-09-30 |
出光興産株式会社 |
有機エレクトロルミネッセンス素子
|
WO2010119264A1
(en)
|
2009-04-16 |
2010-10-21 |
Centro Nacional De Investigaciones Oncólogicas (Cnio) |
Imidazopyrazines for use as kinase inhibitors
|
TW201107329A
(en)
|
2009-07-30 |
2011-03-01 |
Oncotherapy Science Inc |
Fused imidazole derivative having ttk inhibitory action
|
EP2468725B1
(en)
|
2009-08-19 |
2019-07-17 |
Idemitsu Kosan Co., Ltd. |
Aromatic amine derivatives and organic electroluminescent elements using same
|
CN102596961B
(zh)
*
|
2009-10-30 |
2015-12-02 |
詹森药业有限公司 |
咪唑并[1,2-b]哒嗪衍生物及其作为PDE10抑制剂的用途
|
CN102596907B
(zh)
|
2009-11-16 |
2014-12-17 |
出光兴产株式会社 |
芳香族胺衍生物和使用其的有机电致发光元件
|
US9073927B2
(en)
|
2010-01-22 |
2015-07-07 |
Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii |
Inhibitors of PI3 kinase
|
AR080754A1
(es)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
|